ReviewJournal of hematology & oncology2020

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges.

Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.